 Robert Batey
Concepts (431)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Riboswitch | 35 | 2023 | 63 | 14.150 |
Why?
| | Nucleic Acid Conformation | 61 | 2023 | 669 | 6.580 |
Why?
| | RNA, Bacterial | 28 | 2023 | 174 | 6.270 |
Why?
| | RNA | 31 | 2023 | 810 | 5.250 |
Why?
| | Aptamers, Nucleotide | 22 | 2020 | 73 | 3.940 |
Why?
| | Vitamin B 12 | 7 | 2023 | 115 | 3.200 |
Why?
| | RNA Folding | 8 | 2023 | 33 | 3.060 |
Why?
| | Bacillus subtilis | 12 | 2020 | 58 | 3.060 |
Why?
| | Models, Molecular | 36 | 2020 | 1379 | 3.030 |
Why?
| | S-Adenosylmethionine | 12 | 2017 | 54 | 2.840 |
Why?
| | Ligands | 32 | 2023 | 565 | 2.760 |
Why?
| | Purines | 11 | 2019 | 159 | 2.730 |
Why?
| | Base Sequence | 40 | 2023 | 2119 | 2.720 |
Why?
| | Crystallography, X-Ray | 26 | 2022 | 405 | 2.490 |
Why?
| | 5' Untranslated Regions | 10 | 2014 | 51 | 2.300 |
Why?
| | Gene Expression Regulation, Bacterial | 10 | 2022 | 285 | 2.160 |
Why?
| | RNA, Messenger | 17 | 2016 | 2563 | 2.150 |
Why?
| | Transcription, Genetic | 11 | 2020 | 1317 | 1.850 |
Why?
| | Binding Sites | 27 | 2023 | 1173 | 1.680 |
Why?
| | Gene Expression Regulation | 12 | 2020 | 2329 | 1.560 |
Why?
| | Bacterial Proteins | 9 | 2020 | 736 | 1.480 |
Why?
| | RNA, Catalytic | 8 | 2020 | 182 | 1.360 |
Why?
| | Adenine | 7 | 2020 | 220 | 1.340 |
Why?
| | Molecular Sequence Data | 25 | 2015 | 2796 | 1.270 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 6 | 2007 | 18 | 1.220 |
Why?
| | Biosensing Techniques | 2 | 2020 | 99 | 1.170 |
Why?
| | Flavin Mononucleotide | 2 | 2018 | 7 | 1.030 |
Why?
| | Deoxyguanosine | 2 | 2019 | 26 | 1.000 |
Why?
| | Escherichia coli | 10 | 2020 | 719 | 0.990 |
Why?
| | Tetrahydrofolates | 3 | 2015 | 11 | 0.980 |
Why?
| | Genetic Engineering | 3 | 2014 | 80 | 0.950 |
Why?
| | Introns | 4 | 2014 | 227 | 0.880 |
Why?
| | Biochemical Phenomena | 1 | 2023 | 10 | 0.880 |
Why?
| | Bacteria | 4 | 2022 | 728 | 0.860 |
Why?
| | Guanine | 6 | 2011 | 76 | 0.860 |
Why?
| | HMGB Proteins | 1 | 2023 | 15 | 0.850 |
Why?
| | CRISPR-Cas Systems | 2 | 2020 | 78 | 0.830 |
Why?
| | Protein Binding | 16 | 2023 | 1898 | 0.830 |
Why?
| | Models, Genetic | 3 | 2020 | 566 | 0.750 |
Why?
| | Escherichia coli K12 | 1 | 2020 | 7 | 0.740 |
Why?
| | Protein Biosynthesis | 3 | 2016 | 389 | 0.740 |
Why?
| | CRISPR-Associated Proteins | 1 | 2020 | 1 | 0.740 |
Why?
| | Base Pairing | 11 | 2020 | 59 | 0.730 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 18 | 0.730 |
Why?
| | Enzyme Assays | 1 | 2020 | 21 | 0.730 |
Why?
| | Ribosomal Proteins | 6 | 2006 | 70 | 0.720 |
Why?
| | Lysine | 3 | 2012 | 242 | 0.720 |
Why?
| | Chromatography, Affinity | 3 | 2009 | 81 | 0.700 |
Why?
| | Endodeoxyribonucleases | 1 | 2020 | 59 | 0.700 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 60 | 0.680 |
Why?
| | Thermodynamics | 12 | 2014 | 383 | 0.680 |
Why?
| | RNA-Binding Proteins | 6 | 2023 | 352 | 0.680 |
Why?
| | Gene Editing | 1 | 2020 | 57 | 0.670 |
Why?
| | Magnesium | 7 | 2015 | 145 | 0.660 |
Why?
| | Signal Recognition Particle | 5 | 2007 | 8 | 0.630 |
Why?
| | RNA, Long Noncoding | 4 | 2022 | 155 | 0.630 |
Why?
| | Quinoxalines | 1 | 2018 | 60 | 0.610 |
Why?
| | Archaeal Proteins | 2 | 2009 | 45 | 0.590 |
Why?
| | Dihydroxyphenylalanine | 1 | 2017 | 7 | 0.570 |
Why?
| | 5-Hydroxytryptophan | 1 | 2017 | 22 | 0.560 |
Why?
| | Cobamides | 1 | 2017 | 19 | 0.560 |
Why?
| | Mutation | 9 | 2017 | 3350 | 0.560 |
Why?
| | Ribosomes | 3 | 2006 | 148 | 0.560 |
Why?
| | Synthetic Biology | 2 | 2014 | 10 | 0.550 |
Why?
| | Receptors, Glucocorticoid | 3 | 2023 | 131 | 0.550 |
Why?
| | Cyanobacteria | 1 | 2017 | 54 | 0.540 |
Why?
| | Kinetics | 9 | 2017 | 1558 | 0.540 |
Why?
| | Crystallization | 6 | 2019 | 136 | 0.540 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 387 | 0.540 |
Why?
| | Coenzymes | 1 | 2016 | 16 | 0.540 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 80 | 0.530 |
Why?
| | Calorimetry | 3 | 2012 | 61 | 0.520 |
Why?
| | X-Ray Diffraction | 1 | 2016 | 84 | 0.520 |
Why?
| | Conserved Sequence | 8 | 2017 | 218 | 0.510 |
Why?
| | Chemical Fractionation | 1 | 2014 | 28 | 0.460 |
Why?
| | DNA | 6 | 2023 | 1352 | 0.460 |
Why?
| | Folic Acid Antagonists | 1 | 2014 | 8 | 0.460 |
Why?
| | Thermotoga maritima | 3 | 2009 | 10 | 0.460 |
Why?
| | S-Adenosylhomocysteine | 2 | 2010 | 24 | 0.450 |
Why?
| | Ribonucleotides | 5 | 2017 | 25 | 0.430 |
Why?
| | Purine Nucleotides | 1 | 2013 | 12 | 0.430 |
Why?
| | Static Electricity | 5 | 2020 | 114 | 0.420 |
Why?
| | Ribonucleoproteins | 3 | 2020 | 86 | 0.400 |
Why?
| | Streptococcus mutans | 1 | 2011 | 8 | 0.390 |
Why?
| | Substrate Specificity | 5 | 2018 | 355 | 0.390 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 229 | 0.380 |
Why?
| | RNA, Ribosomal, 16S | 4 | 1999 | 487 | 0.370 |
Why?
| | RNA, Archaeal | 2 | 2009 | 13 | 0.360 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1318 | 0.360 |
Why?
| | Mouse Embryonic Stem Cells | 2 | 2020 | 22 | 0.350 |
Why?
| | Anti-Bacterial Agents | 2 | 2018 | 1477 | 0.340 |
Why?
| | Pyrococcus horikoshii | 1 | 2009 | 4 | 0.330 |
Why?
| | Molecular Structure | 4 | 2018 | 438 | 0.330 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2009 | 23 | 0.330 |
Why?
| | Transcription Factors | 5 | 2023 | 1531 | 0.330 |
Why?
| | Ethanol | 5 | 2000 | 548 | 0.320 |
Why?
| | Geobacillus stearothermophilus | 3 | 1998 | 12 | 0.320 |
Why?
| | Models, Chemical | 3 | 2008 | 250 | 0.310 |
Why?
| | Genes, Reporter | 2 | 2020 | 257 | 0.310 |
Why?
| | Gene Expression | 5 | 2014 | 1423 | 0.310 |
Why?
| | Proteobacteria | 1 | 2008 | 16 | 0.300 |
Why?
| | Hydrogen Bonding | 5 | 2012 | 143 | 0.300 |
Why?
| | Fluorescent Dyes | 2 | 2020 | 300 | 0.300 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2000 | 1138 | 0.290 |
Why?
| | Genes, Switch | 1 | 2006 | 5 | 0.280 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 3 | 0.280 |
Why?
| | RNA, Small Nucleolar | 1 | 2006 | 8 | 0.280 |
Why?
| | Pyrimidines | 2 | 2006 | 375 | 0.280 |
Why?
| | Thermoanaerobacter | 1 | 2006 | 1 | 0.270 |
Why?
| | Protein Structure, Secondary | 4 | 2011 | 325 | 0.260 |
Why?
| | Methyltransferases | 1 | 2006 | 61 | 0.260 |
Why?
| | SELEX Aptamer Technique | 1 | 2005 | 14 | 0.260 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2006 | 82 | 0.260 |
Why?
| | Telomerase | 1 | 2008 | 206 | 0.260 |
Why?
| | Magnetic Resonance Spectroscopy | 5 | 2004 | 482 | 0.250 |
Why?
| | Isotope Labeling | 2 | 1996 | 69 | 0.250 |
Why?
| | Mutagenesis | 2 | 2020 | 170 | 0.250 |
Why?
| | Binding, Competitive | 3 | 2020 | 195 | 0.250 |
Why?
| | Hypoxanthine | 1 | 2004 | 10 | 0.240 |
Why?
| | Dexamethasone | 2 | 2023 | 317 | 0.240 |
Why?
| | Liver | 5 | 1998 | 1681 | 0.230 |
Why?
| | Protein Domains | 3 | 2020 | 207 | 0.230 |
Why?
| | Animals | 22 | 2020 | 31867 | 0.230 |
Why?
| | Structure-Activity Relationship | 3 | 2018 | 503 | 0.230 |
Why?
| | Alcohol Dehydrogenase | 2 | 1994 | 16 | 0.230 |
Why?
| | Phylogeny | 4 | 2014 | 796 | 0.220 |
Why?
| | X Chromosome Inactivation | 2 | 2020 | 21 | 0.220 |
Why?
| | Escherichia coli Proteins | 3 | 2007 | 162 | 0.220 |
Why?
| | RNA, Viral | 2 | 2020 | 567 | 0.220 |
Why?
| | Leucovorin | 2 | 2014 | 42 | 0.210 |
Why?
| | RNA, Protozoan | 2 | 2004 | 55 | 0.210 |
Why?
| | Protein Structure, Tertiary | 5 | 2009 | 798 | 0.210 |
Why?
| | Iridium | 2 | 2016 | 7 | 0.210 |
Why?
| | Sequence Deletion | 2 | 2020 | 168 | 0.200 |
Why?
| | Cobalt | 2 | 2016 | 46 | 0.200 |
Why?
| | Estrogen Receptor alpha | 1 | 2022 | 121 | 0.190 |
Why?
| | RNA, Ribosomal | 2 | 2003 | 157 | 0.190 |
Why?
| | Rats, Wistar | 8 | 2000 | 369 | 0.190 |
Why?
| | Cations | 3 | 2016 | 79 | 0.190 |
Why?
| | Leptotrichia | 1 | 2020 | 1 | 0.180 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2000 | 84 | 0.180 |
Why?
| | Molecular Conformation | 3 | 2014 | 137 | 0.180 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 5 | 0.180 |
Why?
| | Terminator Regions, Genetic | 2 | 2011 | 12 | 0.180 |
Why?
| | Hepatitis, Animal | 1 | 2000 | 2 | 0.180 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 29 | 0.180 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1237 | 0.180 |
Why?
| | Drugs, Chinese Herbal | 1 | 2000 | 13 | 0.180 |
Why?
| | X Chromosome | 1 | 2020 | 47 | 0.180 |
Why?
| | Rifampin | 1 | 2020 | 68 | 0.180 |
Why?
| | Endogenous Retroviruses | 1 | 2020 | 19 | 0.180 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 25 | 0.170 |
Why?
| | Theophylline | 1 | 2020 | 60 | 0.170 |
Why?
| | Gram-Negative Aerobic Bacteria | 2 | 1996 | 5 | 0.170 |
Why?
| | Liver Cirrhosis, Alcoholic | 2 | 1998 | 18 | 0.170 |
Why?
| | Point Mutation | 2 | 2011 | 217 | 0.170 |
Why?
| | Nitrogen Isotopes | 2 | 1996 | 55 | 0.160 |
Why?
| | Evolution, Molecular | 3 | 2014 | 437 | 0.160 |
Why?
| | Aminoimidazole Carboxamide | 2 | 2017 | 10 | 0.160 |
Why?
| | Carbon Isotopes | 2 | 1996 | 112 | 0.160 |
Why?
| | Cloning, Molecular | 1 | 2020 | 524 | 0.160 |
Why?
| | Models, Biological | 4 | 2017 | 1636 | 0.160 |
Why?
| | Fluorescence | 2 | 2018 | 148 | 0.160 |
Why?
| | Transcriptome | 1 | 2023 | 725 | 0.150 |
Why?
| | Polymerase Chain Reaction | 4 | 2009 | 999 | 0.150 |
Why?
| | Genes, Bacterial | 3 | 2009 | 158 | 0.150 |
Why?
| | 2-Aminopurine | 2 | 2009 | 10 | 0.150 |
Why?
| | Drug Design | 1 | 2018 | 151 | 0.150 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2017 | 15 | 0.150 |
Why?
| | Aquatic Organisms | 1 | 2017 | 8 | 0.150 |
Why?
| | Endotoxemia | 1 | 1998 | 82 | 0.140 |
Why?
| | Temperature | 3 | 2008 | 578 | 0.140 |
Why?
| | Microscopy, Fluorescence | 1 | 2018 | 398 | 0.140 |
Why?
| | Deuterium | 1 | 1996 | 79 | 0.140 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 53 | 0.130 |
Why?
| | MicroRNAs | 1 | 2022 | 603 | 0.130 |
Why?
| | Affinity Labels | 2 | 2007 | 25 | 0.130 |
Why?
| | Salts | 1 | 2016 | 35 | 0.130 |
Why?
| | Nucleotides | 1 | 1996 | 112 | 0.130 |
Why?
| | Helicobacter pylori | 3 | 2000 | 30 | 0.130 |
Why?
| | Species Specificity | 1 | 2017 | 548 | 0.130 |
Why?
| | Humans | 23 | 2023 | 115039 | 0.130 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2000 | 965 | 0.130 |
Why?
| | Viral Proteins | 3 | 2009 | 281 | 0.130 |
Why?
| | Gastrostomy | 1 | 1996 | 89 | 0.130 |
Why?
| | Genetic Variation | 1 | 2020 | 876 | 0.130 |
Why?
| | Rats | 9 | 2000 | 4973 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2009 | 512 | 0.130 |
Why?
| | Monocytes | 1 | 1998 | 503 | 0.120 |
Why?
| | Protein Engineering | 1 | 2016 | 98 | 0.120 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2014 | 152 | 0.120 |
Why?
| | Protein Conformation | 3 | 2004 | 811 | 0.120 |
Why?
| | T-Lymphocytes | 5 | 2000 | 1747 | 0.120 |
Why?
| | Hydroxocobalamin | 1 | 2014 | 26 | 0.120 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 1995 | 125 | 0.120 |
Why?
| | Interleukin-1 | 2 | 1998 | 970 | 0.120 |
Why?
| | Transcription Termination, Genetic | 1 | 2014 | 12 | 0.110 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 102 | 0.110 |
Why?
| | Plasmids | 2 | 2018 | 345 | 0.110 |
Why?
| | Fatty Liver | 1 | 1995 | 217 | 0.110 |
Why?
| | RNA Stability | 1 | 2014 | 93 | 0.110 |
Why?
| | RNA, Transfer | 1 | 2014 | 118 | 0.110 |
Why?
| | Hepatitis B | 1 | 1993 | 51 | 0.110 |
Why?
| | Concanavalin A | 4 | 2000 | 75 | 0.110 |
Why?
| | HIV Long Terminal Repeat | 1 | 1992 | 7 | 0.110 |
Why?
| | Cytoplasm | 1 | 1993 | 256 | 0.100 |
Why?
| | Methotrexate | 1 | 2014 | 227 | 0.100 |
Why?
| | Tetrahymena thermophila | 2 | 2004 | 58 | 0.100 |
Why?
| | Cytoskeleton | 1 | 1993 | 177 | 0.100 |
Why?
| | Dietary Carbohydrates | 1 | 1993 | 136 | 0.100 |
Why?
| | Mice | 5 | 2020 | 14927 | 0.100 |
Why?
| | Interleukin-6 | 4 | 2000 | 676 | 0.100 |
Why?
| | Guanosine Triphosphate | 2 | 2004 | 85 | 0.100 |
Why?
| | Fusobacterium nucleatum | 1 | 2011 | 3 | 0.100 |
Why?
| | Operator Regions, Genetic | 1 | 1991 | 6 | 0.100 |
Why?
| | Alcohol Drinking | 2 | 1995 | 655 | 0.100 |
Why?
| | Potassium Chloride | 1 | 1991 | 35 | 0.100 |
Why?
| | Drug Discovery | 1 | 2012 | 124 | 0.100 |
Why?
| | Amino Acid Sequence | 2 | 2009 | 1990 | 0.090 |
Why?
| | Bacteriophage lambda | 1 | 1991 | 81 | 0.090 |
Why?
| | Scattering, Small Angle | 1 | 2010 | 20 | 0.090 |
Why?
| | Crystallography | 1 | 2010 | 25 | 0.090 |
Why?
| | Folic Acid | 1 | 2011 | 159 | 0.090 |
Why?
| | Duodenum | 3 | 1996 | 63 | 0.090 |
Why?
| | Adenosine | 2 | 2009 | 204 | 0.090 |
Why?
| | Replication Protein A | 1 | 2009 | 11 | 0.090 |
Why?
| | Clostridium botulinum | 1 | 2009 | 4 | 0.090 |
Why?
| | Gastritis | 2 | 2000 | 84 | 0.080 |
Why?
| | Central Nervous System Depressants | 2 | 2000 | 82 | 0.080 |
Why?
| | DNA, Viral | 1 | 1991 | 349 | 0.080 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2009 | 41 | 0.080 |
Why?
| | Titrimetry | 1 | 2009 | 9 | 0.080 |
Why?
| | Nucleic Acid Denaturation | 1 | 2009 | 31 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 317 | 0.080 |
Why?
| | Glucocorticoids | 2 | 2023 | 535 | 0.080 |
Why?
| | Open Reading Frames | 1 | 2009 | 116 | 0.080 |
Why?
| | 3' Untranslated Regions | 1 | 2009 | 133 | 0.080 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2009 | 51 | 0.080 |
Why?
| | DNA, Bacterial | 2 | 2008 | 311 | 0.080 |
Why?
| | Telomere-Binding Proteins | 1 | 2009 | 88 | 0.080 |
Why?
| | Exons | 1 | 2009 | 301 | 0.080 |
Why?
| | Lipopolysaccharides | 4 | 2000 | 817 | 0.080 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 102 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2009 | 325 | 0.080 |
Why?
| | ortho-Aminobenzoates | 1 | 2008 | 7 | 0.080 |
Why?
| | Repressor Proteins | 1 | 1991 | 368 | 0.080 |
Why?
| | Anhydrides | 1 | 2008 | 18 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 372 | 0.080 |
Why?
| | Telomere | 1 | 2009 | 202 | 0.070 |
Why?
| | History, 21st Century | 1 | 2008 | 161 | 0.070 |
Why?
| | Nucleic Acids | 1 | 2008 | 59 | 0.070 |
Why?
| | Base Pair Mismatch | 1 | 2006 | 14 | 0.070 |
Why?
| | Female | 19 | 2020 | 59611 | 0.070 |
Why?
| | History, 20th Century | 1 | 2008 | 267 | 0.070 |
Why?
| | Interleukin-2 | 2 | 2001 | 415 | 0.070 |
Why?
| | Azoarcus | 1 | 2006 | 1 | 0.070 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2009 | 333 | 0.070 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2006 | 74 | 0.070 |
Why?
| | Alternative Splicing | 1 | 2008 | 188 | 0.070 |
Why?
| | Thiamine Pyrophosphate | 1 | 2006 | 1 | 0.070 |
Why?
| | Sulfur | 1 | 2006 | 46 | 0.070 |
Why?
| | Methylation | 1 | 2006 | 208 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2009 | 551 | 0.060 |
Why?
| | Methionine | 1 | 2006 | 145 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2018 | 590 | 0.060 |
Why?
| | Alanine Transaminase | 3 | 2000 | 140 | 0.060 |
Why?
| | Time Factors | 3 | 2009 | 6141 | 0.060 |
Why?
| | Operon | 1 | 2004 | 59 | 0.060 |
Why?
| | Methanococcus | 1 | 2004 | 9 | 0.060 |
Why?
| | Lymphocyte Activation | 2 | 1998 | 1042 | 0.060 |
Why?
| | Microscopy, Electron | 2 | 1995 | 410 | 0.060 |
Why?
| | Helicobacter Infections | 2 | 2000 | 25 | 0.060 |
Why?
| | Membrane Transport Proteins | 1 | 2004 | 138 | 0.060 |
Why?
| | Male | 7 | 2020 | 55730 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2014 | 171 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 193 | 0.050 |
Why?
| | Enterocytes | 1 | 2001 | 14 | 0.050 |
Why?
| | Antigens, Bacterial | 2 | 2000 | 112 | 0.050 |
Why?
| | Cell Membrane Permeability | 1 | 2001 | 83 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 337 | 0.050 |
Why?
| | RNA, Untranslated | 1 | 2022 | 113 | 0.050 |
Why?
| | RNA Splicing | 1 | 2022 | 246 | 0.050 |
Why?
| | Endopeptidases | 1 | 2001 | 72 | 0.050 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 138 | 0.050 |
Why?
| | Dosage Compensation, Genetic | 1 | 2020 | 11 | 0.040 |
Why?
| | Transformation, Bacterial | 1 | 2000 | 5 | 0.040 |
Why?
| | Hepatitis, Alcoholic | 1 | 1999 | 13 | 0.040 |
Why?
| | Chromatin | 1 | 2023 | 428 | 0.040 |
Why?
| | Potassium | 1 | 2000 | 128 | 0.040 |
Why?
| | Interferon-gamma | 2 | 2000 | 723 | 0.040 |
Why?
| | RNA, Small Nuclear | 1 | 2018 | 31 | 0.040 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 1998 | 11 | 0.040 |
Why?
| | Color | 1 | 2018 | 74 | 0.040 |
Why?
| | Kupffer Cells | 1 | 1998 | 45 | 0.040 |
Why?
| | Tetrahymena | 1 | 1998 | 155 | 0.040 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2017 | 3 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2020 | 556 | 0.040 |
Why?
| | RNA-Binding Protein FUS | 1 | 2017 | 11 | 0.040 |
Why?
| | G-Quadruplexes | 1 | 2017 | 15 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 295 | 0.040 |
Why?
| | Dinucleoside Phosphates | 1 | 2017 | 24 | 0.040 |
Why?
| | Cell Line | 2 | 2020 | 2645 | 0.040 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2017 | 51 | 0.040 |
Why?
| | Diethyl Pyrocarbonate | 1 | 1996 | 2 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 1996 | 10 | 0.030 |
Why?
| | HeLa Cells | 1 | 2018 | 562 | 0.030 |
Why?
| | Gastroscopy | 1 | 1996 | 18 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 238 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 373 | 0.030 |
Why?
| | Thionucleotides | 1 | 1996 | 34 | 0.030 |
Why?
| | Water | 1 | 2000 | 409 | 0.030 |
Why?
| | Protein Folding | 1 | 1998 | 239 | 0.030 |
Why?
| | Endoribonucleases | 1 | 2017 | 62 | 0.030 |
Why?
| | Hydrazines | 1 | 1996 | 28 | 0.030 |
Why?
| | Oligoribonucleotides | 1 | 1996 | 52 | 0.030 |
Why?
| | Glutamine | 1 | 2017 | 91 | 0.030 |
Why?
| | Iodine | 1 | 1996 | 18 | 0.030 |
Why?
| | New South Wales | 2 | 1993 | 10 | 0.030 |
Why?
| | Cell Membrane | 1 | 2000 | 681 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1996 | 96 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1996 | 345 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 1995 | 17 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1996 | 157 | 0.030 |
Why?
| | Craniocerebral Trauma | 1 | 1996 | 128 | 0.030 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1996 | 218 | 0.030 |
Why?
| | Culture Media | 1 | 1995 | 155 | 0.030 |
Why?
| | Hydrolysis | 1 | 1995 | 174 | 0.030 |
Why?
| | Tissue Embedding | 1 | 1993 | 3 | 0.030 |
Why?
| | Hepatitis B Core Antigens | 1 | 1993 | 4 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 1996 | 247 | 0.030 |
Why?
| | Hepatitis B Antibodies | 1 | 1993 | 10 | 0.030 |
Why?
| | Hepatitis B Surface Antigens | 1 | 1993 | 18 | 0.030 |
Why?
| | Killer Cells, Lymphokine-Activated | 1 | 1993 | 9 | 0.030 |
Why?
| | Hepatitis B virus | 1 | 1993 | 25 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 1996 | 252 | 0.030 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1993 | 84 | 0.030 |
Why?
| | Urban Health | 1 | 1993 | 73 | 0.030 |
Why?
| | Glucose Solution, Hypertonic | 1 | 1993 | 1 | 0.030 |
Why?
| | Seroepidemiologic Studies | 1 | 1993 | 138 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 1993 | 100 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1995 | 474 | 0.030 |
Why?
| | Metabolic Clearance Rate | 1 | 1993 | 106 | 0.030 |
Why?
| | Middle Aged | 7 | 2000 | 26827 | 0.030 |
Why?
| | Cell Division | 3 | 2001 | 758 | 0.030 |
Why?
| | Methylococcaceae | 1 | 1992 | 2 | 0.030 |
Why?
| | Fructose | 1 | 1993 | 100 | 0.030 |
Why?
| | Cytokines | 3 | 1996 | 1843 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 2715 | 0.020 |
Why?
| | Autoradiography | 1 | 1991 | 70 | 0.020 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1991 | 26 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 1991 | 27 | 0.020 |
Why?
| | Electrochemistry | 1 | 1991 | 78 | 0.020 |
Why?
| | Aged, 80 and over | 3 | 2000 | 6357 | 0.020 |
Why?
| | Antigens, CD | 1 | 1993 | 441 | 0.020 |
Why?
| | Urease | 2 | 2000 | 8 | 0.020 |
Why?
| | Heroin Dependence | 1 | 1989 | 22 | 0.020 |
Why?
| | Case-Control Studies | 1 | 1996 | 3015 | 0.020 |
Why?
| | Chloride Channels | 2 | 2001 | 35 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 198 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 1993 | 561 | 0.020 |
Why?
| | Methadone | 1 | 1989 | 77 | 0.020 |
Why?
| | Lymphocyte Count | 2 | 1998 | 133 | 0.020 |
Why?
| | Phosphorylation | 1 | 1992 | 1572 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 797 | 0.020 |
Why?
| | Prevalence | 1 | 1993 | 2255 | 0.020 |
Why?
| | Computer Simulation | 1 | 2011 | 880 | 0.020 |
Why?
| | Aged | 4 | 2000 | 19119 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1995 | 3545 | 0.020 |
Why?
| | Ambulatory Care | 1 | 1989 | 478 | 0.020 |
Why?
| | Adult | 6 | 2000 | 30655 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1989 | 430 | 0.020 |
Why?
| | Blood Glucose | 1 | 1993 | 1821 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2001 | 3896 | 0.010 |
Why?
| | Immunohistochemistry | 2 | 1998 | 1634 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 1993 | 4411 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1996 | 9122 | 0.010 |
Why?
| | Xanthine | 1 | 2001 | 7 | 0.010 |
Why?
| | Colforsin | 1 | 2001 | 44 | 0.010 |
Why?
| | Thymidine | 1 | 2001 | 58 | 0.010 |
Why?
| | Mannitol | 1 | 2001 | 32 | 0.010 |
Why?
| | Receptors, Interleukin-2 | 1 | 2001 | 64 | 0.010 |
Why?
| | RNA Probes | 1 | 2001 | 13 | 0.010 |
Why?
| | Hepatitis Delta Virus | 1 | 2001 | 6 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2001 | 12 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2001 | 226 | 0.010 |
Why?
| | Dyspepsia | 1 | 2000 | 9 | 0.010 |
Why?
| | Intestine, Small | 1 | 2001 | 122 | 0.010 |
Why?
| | Blood Cells | 1 | 2000 | 38 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 46 | 0.010 |
Why?
| | CD4 Antigens | 1 | 2000 | 124 | 0.010 |
Why?
| | Retrospective Studies | 1 | 1996 | 12547 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2000 | 209 | 0.010 |
Why?
| | Mitogens | 1 | 1999 | 58 | 0.010 |
Why?
| | Interleukin-8 | 1 | 2000 | 238 | 0.010 |
Why?
| | Immunoglobulin A | 1 | 2000 | 171 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 928 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2001 | 1229 | 0.010 |
Why?
| | Endotoxins | 1 | 1999 | 205 | 0.010 |
Why?
| | Lymphocyte Subsets | 1 | 1998 | 79 | 0.010 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2001 | 287 | 0.010 |
Why?
| | Disaccharidases | 1 | 1996 | 1 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2000 | 776 | 0.010 |
Why?
| | Ion Transport | 1 | 1996 | 55 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 61 | 0.010 |
Why?
| | Keratins | 1 | 1996 | 176 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 383 | 0.010 |
Why?
| | Immunoblotting | 1 | 1996 | 282 | 0.010 |
Why?
| | Epithelium | 1 | 1996 | 297 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1591 | 0.010 |
Why?
| | Child | 1 | 1993 | 18407 | 0.010 |
Why?
| | Cycloheximide | 1 | 1994 | 55 | 0.010 |
Why?
| | DNA Probes | 1 | 1994 | 59 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2000 | 1268 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 140 | 0.010 |
Why?
| | CD56 Antigen | 1 | 1993 | 34 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 1994 | 168 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1993 | 67 | 0.010 |
Why?
| | CD3 Complex | 1 | 1993 | 92 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1998 | 691 | 0.010 |
Why?
| | DNA Primers | 1 | 1994 | 514 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1993 | 192 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1993 | 196 | 0.010 |
Why?
| | Interleukins | 1 | 1994 | 236 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1994 | 1036 | 0.010 |
Why?
| | Epithelial Cells | 1 | 1996 | 956 | 0.010 |
Why?
| | Apoptosis | 1 | 1999 | 2366 | 0.010 |
Why?
| | Fibroblasts | 1 | 1994 | 839 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1989 | 169 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 1993 | 528 | 0.000 |
Why?
| | Prospective Studies | 1 | 1989 | 6232 | 0.000 |
Why?
| | Pregnancy | 1 | 1989 | 5519 | 0.000 |
Why?
|
|
Batey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|